Home  |  Contact

Cellosaurus KR-12 (CVCL_3732)

[Text version]

Cell line name KR-12
Synonyms KR12
Accession CVCL_3732
Resource Identification Initiative To cite this cell line use: KR-12 (RRID:CVCL_3732)
Comments Group: Hybridoma fusion partner cell line.
Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_0014 (RPMI-8226)
Parent: CVCL_H617 (GM1500-6TG-OUB)
Children:
CVCL_XI30 (1F42E31FG7)CVCL_A6HW (MAC 40/43)CVCL_A5IR (MP 4109)
CVCL_A5IS (MP 4112)CVCL_A5IT (MP 4126)
Category Hybrid cell line
STR profile Source(s): ATCC

Markers:
AmelogeninX,Y
CSF1PO10,12
D5S81810,11,13
D7S8209,10
D13S31711,12
D16S5399,11
TH018,9,9.3
TPOX8
vWA16,18,19

Run an STR similarity search on this cell line
Publications

PubMed=6092464
Kozbor D., Tripputi P., Roder J.C., Croce C.M.
A human hybrid myeloma for production of human monoclonal antibodies.
J. Immunol. 133:3001-3005(1984)

Patent=US4693975
Kozbor D., Croce C.M.
Human hybridoma fusion partner for production of human monoclonal antibodies.
Patent number US4693975, 15-Sep-1987

PubMed=3365703
Kjeldsen T.B., Rasmussen B.B., Rose C., Zeuthen J.
Human-human hybridomas and human monoclonal antibodies obtained by fusion of lymph node lymphocytes from breast cancer patients.
Cancer Res. 48:3208-3214(1988)

Cross-references
Cell line collections ATCC; CRL-8658 - Discontinued
TKG; TKG 0216
Ontologies CLO; CLO_0007119
Biological sample resources BioSample; SAMN03471206
Other Wikidata; Q54900448
Entry history
Entry creation04-Apr-2012
Last entry update20-May-2021
Version number12